Charleston Neuroscience Institute

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Diabetic eye disease4 trials
• Macular degeneration3 trials

Phase

• Phase 33 trials
• Phase 22 trials
• Phase 2/32 trials

Status

• Completed4 trials
• Active, not recruiting2 trials
• Recruiting1 trial

Lead sponsor

• 4D Molecular Therapeutics1 trial
• EyeBiotech Ltd.1 trial
• Greater Houston Retina Research1 trial
• Hoffmann-La Roche1 trial
• Novartis Pharmaceuticals1 trial
• and 2 more

Running trials

• Recruiting

  A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

  NCT07496567· Phase 2/3· EyeBiotech Ltd.· Source

  Contact: Study Coordinator

• Active, not recruiting

  4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

  NCT06864988· Phase 3· 4D Molecular Therapeutics· Source

• Active, not recruiting

  Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration

  NCT06223958· Phase 3· Ocular Therapeutix, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Macular degeneration1 recruiting

Closed trials

• Completed

  Safety and Efficacy of Faricimab in Patients With NPDR

  NCT05681884· Phase 2· Greater Houston Retina Research· Source

• Completed

  A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema

  NCT05151731· Phase 2· Hoffmann-La Roche· Source

• Completed

  A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1)

  NCT05066997· Phase 2/3· Oculis· Source

• Completed

  Study of Efficacy and Safety of Brolucizumab Versus Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy

  NCT04278417· Phase 3· Novartis Pharmaceuticals· Source